CRSP Free Cash Flow
Crispr Therapeutics Ag · Free Cash Flow
CRSP Free Cash Flow
Latest reported-$373.80Mperiod ending
CRSP TTM Free Cash Flow ($58.27M → -$373.80M)
TTM free cash flow
High-resolution chart · PNG
CRSP free cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Free Cash Flow (USD) |
|---|---|
| -373,798,000 | |
| -401,176,000 | |
| -345,928,000 | |
| -303,143,000 | |
| -325,567,000 | |
| -307,859,000 | |
| -144,675,000 | |
| -191,201,000 | |
| -126,043,000 | |
| -166,554,000 | |
| -269,845,000 | |
| -292,553,000 | |
| -361,814,000 | |
| -376,600,000 | |
| -532,929,000 | |
| -508,631,000 | |
| -515,774,000 | |
| 414,365,000 | |
| 457,267,000 | |
| 465,037,000 | |
| 502,192,000 | |
| -309,245,000 | |
| -256,724,000 | |
| -166,849,000 | |
| 45,333,000 | |
| 39,661,000 | |
| 49,993,000 | |
| 18,197,000 | |
| -133,421,000 | |
| -120,603,000 | |
| -99,012,000 | |
| -84,687,000 | |
| -82,890,000 | |
| -74,457,000 | |
| -77,911,000 | |
| -82,508,000 | |
| -77,431,000 | |
| -74,777,000 | |
| -58,326,000 | |
| 29,819,000 | |
| 37,742,000 | |
| 49,611,000 | |
| 58,274,000 |